Drug Shortage Report for CEFTRIAXONE INJECTION, USP
| Report ID | 247690 |
| Drug Identification Number | 02499738 |
| Brand name | CEFTRIAXONE INJECTION, USP |
| Common or Proper name | Ceftriaxone Injection USP 2000 mg / 50 mL |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 2000MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | CA2G3505– 24 bags/case |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-01-20 |
| Actual start date | 2025-01-20 |
| Estimated end date | 2025-01-31 |
| Actual end date | 2025-01-31 |
| Shortage status | Resolved |
| Updated date | 2025-02-01 |
| Company comments | Potential shortage is due to delays in manufacturing and shipping, and we expect to be back in stock by Jan 31st. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-02-01 | English | Compare |
| v5 | 2025-01-31 | French | Compare |
| v4 | 2025-01-31 | English | Compare |
| v3 | 2025-01-21 | English | Compare |
| v2 | 2025-01-14 | French | Compare |
| v1 | 2025-01-14 | English | Compare |
Showing 1 to 6 of 6